Clinical Pharmacology (Science and Research)

The mission of clinical pharmacologists in the Center for Drug Evaluation and Research (CDER) is to ensure the safety and effectiveness of new drugs through the evaluation of clinical pharmacology and biopharmaceutics data in support of CDER's Investigational New Drug (IND), New Drug Application (NDA), and Biologics License Application (BLA) review programs.  

Clinical pharmacology staff members perform research to expand the FDA’s knowledge of clinical pharmacology in order to better evaluate benefit and risk, and to ensure that regulatory policy and decision making are based on the best available science.

Related Information

Page Last Updated: 02/22/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English